New malaria combo aims to stop relapses for good
Cure
Not yet recruiting
This Phase 2b trial tests whether a new drug, SJ733, combined with tafenoquine can cure P. vivax malaria and prevent it from returning. About 104 adults with uncomplicated malaria will receive different schedules of SJ733 plus tafenoquine, or standard chloroquine plus tafenoquine…
Phase 2 • Sponsor: R. Kiplin Guy • Aim: Cure
Last updated Aug 01, 2026 00:00 UTC